MedTrace Logo

Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose

NCT00868660 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2010-11-02

No results posted yet for this study

Summary

Healthy Normal Single Ascending Dose and Crohn's patient Multiple Ascending Dose

Conditions

Interventions

DRUG

ZP1848

sc. bolus

Sponsors & Collaborators

Principal Investigators

  • Christian Thorkildsen · Zealand Pharma A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00868660 on ClinicalTrials.gov